Cogniant’s clinical stage multi-modal digital biomarkers company utilizing movement, mobility, sleep, voice, usage, cognition data passively to improve screening and diagnostic pathways and disease monitoring for patients of rare diseases, co-morbid depression, pain and mild cognitive impairments.